Nuwellis (Nasdaq:NUWE) announced that it received notice from the Nasdaq market that it regained compliance with certain requirements.
Minneapolis-based Nuwellis last month received a 180-day extension from Nasdaq to regain compliance. That followed a 180-day period in which the company failed to do so.
Nasdaq granted the company time until May 29, 2023, to get its common shares to close at or above $1 for 10 consecutive business days. Shares of NUWE closed yesterday at $6.67 apiece. The market sent Nuwellis formal notice that it evidenced full compliance with the minimum bid price requirement.
The company advised that the matter is now closed, according to a news release.
Nuwellis has focused on developing, manufacturing, and commercializing its Aquadex SmartFlow system for ultrafiltration therapy. It formerly operated under the name “CHF Solutions.” The company rebranded to Nuwellis in April 2021.
The company describes Aquadex SmartFlow as a simple, flexible and smart method of removing excess fluid from patients suffering from hypervolemia (fluid overload).
https://www.massdevice.com/nuwellis-compliance-nasdaq-listing-requirements/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.